ID   COG-LL-355
AC   CVCL_B3TK
DR   Wikidata; Q110432733
RX   PubMed=19298590;
WW   Provider; CCR; -; https://www.cccells.org/PDF_Files/LL-PDX/COG-LL-355.pdf
WW   Provider; CCR; -; https://www.cccells.org/tables/Lymphoid.php
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
ST   Source(s): COG
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12,13
ST   D16S539: 9,11
ST   D18S51: 12
ST   D19S433: 14
ST   D21S11: 28,30
ST   D2S1338: 19
ST   D3S1358: 14,15
ST   D5S818: 12
ST   D7S820: 10,11
ST   D8S1179: 12,16
ST   FGA: 19,23
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia
DI   ORDO; Orphanet_99860; Precursor B-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M164 ! COG-LL-355h
SX   Male
AG   7Y
CA   Cancer cell line
DT   Created: 16-12-21; Last updated: 10-04-25; Version: 6
//
RX   PubMed=19298590; DOI=10.1111/j.1365-2141.2009.07631.x;
RA   Kang M.H., Harutyunyan N., Hall C.P., Papa R.A., Lock R.B.;
RT   "Methotrexate and aminopterin exhibit similar in vitro and in vivo
RT   preclinical activity against acute lymphoblastic leukaemia and
RT   lymphoma.";
RL   Br. J. Haematol. 145:389-393(2009).
//